Physician profile
Mohammed Kazimuddin
NPI 1053310409
$16,535.24
in general payments reported to CMS, 2019-2025
47 companies · $11K in 2025
The $11K reported for 2025 was more than what 89% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,053 · 2020: $511 · 2021: $1,057 · 2022: $1,415 · 2023: $879 · 2024: $1,024 · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $9,286 · Food and Beverage: $3,119 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $9,286.32 |
| Food and Beverage | $3,118.72 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lantheus Medical Imaging, INC. | $9,286.32 | 2025 | |
| Janssen Pharmaceuticals, INC | $849.60 | 2019-2024 | Xarelto |
| Amgen INC. | $655.77 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $630.02 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $619.76 | 2019-2024 | |
| Abiomed | $550.21 | 2021-2025 | Impella |
| Boston Scientific Corporation | $449.43 | 2021-2025 | Ekosonic, Eluvia, Cds - Mct/Cem Monitoring |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $328.84 | 2019-2025 | Lifevest |
| Astrazeneca Pharmaceuticals Lp | $326.83 | 2019-2025 | Farxiga, Brilinta, Wainua |
| Chiesi USA, INC. | $263.57 | 2020-2025 | Kengreal, Cleviprex |
| Inari Medical, INC. | $241.34 | 2019-2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Sanofi-Aventis U.S. LLC | $230.84 | 2019-2023 | |
| E.R. Squibb & Sons, L.L.C. | $227.32 | 2019-2025 | Eliquis, Camzyos |
| Actelion Pharmaceuticals US, INC. | $225.74 | 2019-2023 | Opsumit, Uptravi |
| Philips North America LLC | $178.00 | 2020-2024 | (Ck4) Mcot |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $140.50 | 2019 | |
| Alnylam Pharmaceuticals INC. | $124.68 | 2022-2025 | Onpattro, Amvuttra |
| Teleflex LLC | $113.26 | 2022 | |
| Kiniksa Pharmaceuticals International, Plc | $109.56 | 2024 | Arcalyst |
| Shockwave Medical, INC | $100.13 | 2021-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Amarin Pharma, INC. | $69.72 | 2019-2021 | |
| Abbott Laboratories | $63.47 | 2021-2022 | |
| Osprey Medical INC | $59.43 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $50.46 | 2021-2023 | Verquvo |
| Kiniksa Pharmaceuticals, Ltd. | $50.36 | 2023 | Arcalyst |
| Heartflow, INC. | $50.05 | 2025 | |
| Mallinckrodt Hospital Products INC. | $49.02 | 2021 | |
| Thrombolex, INC. | $39.85 | 2024-2025 | Bashir Endovascular Catheter |
| Baxter Healthcare | $39.08 | 2025 | Hillrom - Carnation Ambulatory Monitor |
| Zoll Circulation INC | $37.85 | 2025 | Therox Ds2 Console, Catheter, Downstream Cartridge |
| Viatris Specialty LLC | $34.25 | 2025 | Yupelri |
| Lundbeck LLC | $32.94 | 2019 | |
| Grifols USA, LLC | $32.03 | 2023-2024 | Prolastin-C Liquid |
| Boehringer Ingelheim Pharmaceuticals, INC. | $30.69 | 2021-2022 | |
| Novo Nordisk INC | $28.18 | 2019-2025 | Wegovy |
| Daiichi Sankyo INC. | $23.72 | 2025 | Injectafer |
| Atricure, INC. | $21.88 | 2022 | |
| Ambu INC. | $21.73 | 2022 | |
| Portola Pharmaceuticals, LLC | $18.76 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $18.25 | 2020 | |
| Corindus INC. | $18.19 | 2019 | |
| Livanova USA, INC. | $17.62 | 2022 | |
| Verona Pharma, INC. | $16.86 | 2025 | Ohtuvayre |
| Electromed, INC. | $15.73 | 2023 | Smartvest |
| Regeneron Healthcare Solutions, INC. | $15.15 | 2019 | |
| Cook Medical LLC | $14.57 | 2019 | |
| Vifor Pharma, INC. | $13.68 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammed Kazimuddin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.